PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
Clinical trials for PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED trials appear
Sign up with your email to follow new studies for PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat blood cancer? trial tests adding drugs to standard chemo
Disease control TerminatedThis study aims to see if adding one of two new drugs (duvelisib or CC-486) to a standard chemotherapy regimen works better for treating newly diagnosed peripheral T-cell lymphoma, a rare and aggressive blood cancer. It will compare the complete remission rates and side effects b…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 31, 2026 12:22 UTC
-
Targeted attack on rare blood cancers shows promise
Disease control OngoingThis study is testing a new treatment approach for aggressive types of T-cell lymphoma, a rare blood cancer. It combines a targeted drug that seeks out cancer cells with standard chemotherapy drugs. The goal is to see if this combination is safe and more effective at controlling …
Matched conditions: PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Could a simple vitamin pill help fight cancer?
Disease control OngoingThis study is testing whether giving vitamin D supplements to cancer patients who have low vitamin D levels can help improve their survival and delay the need for other treatments. It focuses on people newly diagnosed with certain aggressive lymphomas or a slow-growing type of le…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC